Accuracy of lipoprotein lipids and apoproteins in predicting coronary heart disease in diabetic American Indians. The Strong Heart Study (Q43906724)

27 November 2017

Accuracy of lipoprotein lipids and apoproteins in predicting coronary heart disease in diabetic American Indians. The Strong Heart Study (English)

1 reference

27 November 2017

coronary artery disease

1 reference

5

Elisa T Lee

1 reference

27 November 2017

7

Barbara V Howard

1 reference

27 November 2017

6

Thomas K Welty

1 reference

27 November 2017

Kathleen A. Jablonski

series ordinal

2

object named as

Kathleen A Jablonski

1 reference

27 November 2017

Dongsheng Hu

1

1 reference

27 November 2017

Yvonne H Sparling

series ordinal

3

1 reference

27 November 2017

David C Robbins

series ordinal

4

1 reference

27 November 2017

language of work or name

1 reference

1 February 2002

1 reference

27 November 2017

Annals of Epidemiology

1 reference

27 November 2017

12

1 reference

27 November 2017

2

1 reference

27 November 2017

79-85

1 reference

All-cause mortality and cardiovascular disease mortality in three American Indian populations, aged 45-74 years, 1984-1988. The Strong Heart Study.

27 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900208-3

7 January 2021

Rising tide of cardiovascular disease in American Indians. The Strong Heart Study

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900208-3

7 January 2021

Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993.

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900208-3

7 January 2021

Coronary heart disease prevalence and its relation to risk factors in American Indians. The Strong Heart Study.

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900208-3

7 January 2021

Diabetes and coronary heart disease in American Indians: The Strong Heart Study

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900208-3

7 January 2021

Prediction of Coronary Heart Disease Using Risk Factor Categories

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900208-3

7 January 2021

Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S)

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900208-3

7 January 2021

Apolipoprotein profile in type II diabetic patients with and without coronary heart disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900208-3

7 January 2021

Lipids and lipoproteins as coronary risk factors in non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900208-3

7 January 2021

Triglyceride enriched lipoprotein particles correlate with the severity of coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900208-3

7 January 2021

The severity of coronary atherosclerosis in type 2 diabetes mellitus is related to the number of circulating triglyceride-rich lipoprotein particles.

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900208-3

7 January 2021

Association of lipoprotein cholesterol and triglycerides with the severity of coronary artery disease in men and women.

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900208-3

7 January 2021

The Strong Heart Study. A study of cardiovascular disease in American Indians: design and methods

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900208-3

7 January 2021

Apolipoprotein E polymorphism in American Indians and its relation to plasma lipoproteins and diabetes. The Strong Heart Study.

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900208-3

7 January 2021

Sustained reduction of proteinuria in type 2 (non-insulin-dependent) diabetes following diet-induced reduction of hyperglycaemia

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900208-3

7 January 2021

The meaning and use of the area under a receiver operating characteristic (ROC) curve

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900208-3

7 January 2021

A method of comparing the areas under receiver operating characteristic curves derived from the same cases

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900208-3

7 January 2021

Plasma lipid abnormalities and risk factors for coronary artery disease in Japanese subjects with diabetes mellitus and glucose intolerance

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900208-3

7 January 2021

Lipids and lipoproteins predicting coronary heart disease mortality and morbidity in patients with non-insulin-dependent diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900208-3

7 January 2021

Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23)

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900208-3

7 January 2021

HDL subparticles and coronary artery disease in NIDDM.

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900208-3

7 January 2021

LDL cholesterol as a strong predictor of coronary heart disease in diabetic individuals with insulin resistance and low LDL: The Strong Heart Study

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900208-3

7 January 2021

Cholesterol absorption and lipoprotein metabolism in type II diabetes mellitus with and without coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900208-3

7 January 2021

Diabetes, hyperlipidemia, and coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900208-3

7 January 2021

Cardiovascular outcomes in type 2 diabetes. A double-blind placebo-controlled study of bezafibrate: the St. Mary's, Ealing, Northwick Park Diabetes Cardiovascular Disease Prevention (SENDCAP) Study

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900208-3

7 January 2021

Lipids and lipoproteins as risk factors for coronary heart disease in non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900208-3

7 January 2021

Apolipoproteins and coronary artery disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900208-3

7 January 2021

Multiple regression analysis of sixteen risk factors including serum apolipoproteins in angiographically documented coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900208-3

7 January 2021

Relationship between HDL-cholesterol and apolipoprotein A1 and the severity of coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900208-3

7 January 2021

10.1016/S1047-2797(01)00208-3

Identifiers

DOI

1 reference

27 November 2017

1 reference